LAVA Therapeutics NV - Common shares, Euro 0.12 nominal value per share (LVTX)

25 filings reported holding LVTX - LAVA Therapeutics NV - Common shares, Euro 0.12 nominal value per share as of Q3 2024.
LAVA Therapeutics NV - Common shares, Euro 0.12 nominal value per share (LVTX) has 20 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 3.61M shares of 26M outstanding shares and own 13.87% of the company stock.
Largest 10 shareholders include Redmile Group, LLC (2.07M shares), Bruce & Co., Inc. (772K shares), SPHERA FUNDS MANAGEMENT LTD. (146K shares), TWO SIGMA INVESTMENTS, LP (103K shares), Pathway Financial Advisors LLC (103K shares), Alpha Wave Global, LP (87.4K shares), PNC Financial Services Group, Inc. (65K shares), TANG CAPITAL MANAGEMENT LLC (53.1K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (48.2K shares), and MORGAN STANLEY (36.4K shares).
This table shows the top 20 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.